A Multicenter, Open-label, 6 Week Study to Evaluate the Efficacy and Safety of Algorithm Based Intensive Treatment With Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Patients.

Trial Profile

A Multicenter, Open-label, 6 Week Study to Evaluate the Efficacy and Safety of Algorithm Based Intensive Treatment With Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Patients.

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 03 Dec 2012

At a glance

  • Drugs Ezetimibe/simvastatin; HMG-CoA reductase inhibitors
  • Indications Hypercholesterolaemia
  • Focus Therapeutic Use
  • Acronyms VYCTORY
  • Sponsors Merck & Co
  • Most Recent Events

    • 03 Dec 2012 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 20 Sep 2012 Planned initiation date changed from 1 Sep 2012 to 1 Mar 2013 as reported by ClinicalTrials.gov.
    • 20 Sep 2012 Planned End Date changed from 1 Jan 2014 to 1 May 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top